Mahmood Ladha
Präsident bei DOVA PHARMACEUTICALS, INC.
Aktive Positionen von Mahmood Ladha
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 01.01.2019 | - |
DOVA PHARMACEUTICALS, INC. | Präsident | 12.11.2019 | - |
Karriereverlauf von Mahmood Ladha
Ehemalige bekannte Positionen von Mahmood Ladha
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Mahmood Ladha
University of South Carolina | Masters Business Admin |
Statistik
International
Schweden | 3 |
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
Private Unternehmen | 2 |
---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Dova Pharmaceuticals, Inc.
Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
- Börse
- Insiders
- Mahmood Ladha
- Erfahrung